Kymera Therapeutics Inc (KYMR)
R&D Expenses
$375.60M
TTM · Period ending: · USD
KYMR R&D Expenses
Latest reported$375.60Mperiod ending
Latest reported$375.60Mperiod ending
KYMR TTM R&D Expenses ($62.11M → $375.60M)
TTM R&D Expenses
High-resolution chart · PNG
KYMR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 375,600,000 | |
| 334,507,000 | |
| 316,600,000 | |
| 304,554,000 | |
| 290,870,000 | |
| 271,684,000 | |
| 240,248,000 | |
| 221,401,000 | |
| 209,108,000 | |
| 195,673,000 | |
| 189,081,000 | |
| 179,244,000 | |
| 175,004,000 | |
| 170,530,000 | |
| 164,247,000 | |
| 158,644,000 | |
| 153,073,000 | |
| 147,000,000 | |
| 137,018,000 | |
| 119,880,000 | |
| 97,352,000 | |
| 75,951,000 | |
| 62,105,000 | |
| 52,799,000 | |
| 48,331,000 |